← Oncology Approval Tracker

FDA DECISION ·

Bosulif

bosutinib · Pfizer

Traditional approvalTraditional conversionChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

LAMPGEN ANALYSIS

Why it matters

The action converts a first-line chronic-phase indication originally granted accelerated approval in 2017.

What research teams should watch

Separate newly diagnosed chronic phase from resistant and advanced-phase use when coding a treatment cohort.

PRIMARY RECORDS

Sources